CFM
VERA icon

Catalyst Funds Management’s Vera Therapeutics VERA Stock Holding History

Catalyst Funds Management’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,200
Closed -$53K – 1238
2024
Q3 		$53K Buy
+1,200
New +$45.5K 0.01% 772

Other funds holding VERA

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
SC
Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return

Catalyst Funds Management's VERA Position: Q4 2024 in Review

Catalyst Funds Management sold out of Vera Therapeutics (VERA) in Q4 2024, closing a stake of 1,200 shares — an estimated $53K sold.

Catalyst Funds Management first reported a position in VERA in Q3 2024 and held it in 1 quarter. The position peaked at $53K in Q3 2024. 178 funds tracked by Wall St. Rank hold VERA as of Q4 2024.

  • Catalyst Funds Management reported no remaining Vera Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Catalyst Funds Management sold 1,200 Vera Therapeutics shares in Q4 2024, an estimated $53K.
  • Catalyst Funds Management first reported a position in Vera Therapeutics in Q3 2024 and held it in 1 quarter.
  • Catalyst Funds Management's Vera Therapeutics position peaked at $53K in Q3 2024.
  • 178 funds tracked by Wall St. Rank held Vera Therapeutics as of Q4 2024.

Based on Catalyst Funds Management's 13F filing for Q4 2024, filed 10 Feb 2025.